fentanyl has been researched along with buprenorphine, naloxone drug combination in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 8 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan-Cummings, AM; Crampton, K; Drexler, K; Fareed, A; Grant, A | 1 |
| Carroll, JJ; Green, TC; Marshall, BDL; Rich, JD | 1 |
| Azar, P; Miles, I; Nikoo, M | 1 |
| Bisaga, A | 1 |
| Danilewitz, M; McLean, M | 1 |
| Antoine, D; Dunn, KE; Hammond, AS; Huhn, AS; Jardot, J; Strain, EC; Turner, G | 1 |
| Kiyokawa, M; Murata, KA; Quattlebaum, THN | 1 |
| DeBeck, K; Fairbairn, N; Grant, C; Hayashi, K; Milloy, MJ; Wood, E; Young, S | 1 |
| Brar, R; Fairbairn, N; Shearer, D; Young, S | 1 |
| Bozinoff, N; Bruneau, J; Choi, JC; Hassan, A; Jutras-Aswad, D; Le Foll, B; Lim, R; Mok, WY; Rehm, J; Socias, ME; Wild, TC; Wood, E | 1 |
| Comer, SD; Foltin, RW; Nagaraj, N; Scranton, RE; Sykes, KA; Zale, S | 1 |
| Borys, S; Chaguturu, V; Chesin, M; Kline, A; Mattern, D; Steinberg, ML; Williams, JM | 1 |
1 trial(s) available for fentanyl and buprenorphine, naloxone drug combination
| Article | Year |
|---|---|
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Female; Fentanyl; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2022 |
11 other study(ies) available for fentanyl and buprenorphine, naloxone drug combination
| Article | Year |
|---|---|
Reversal of overdose on fentanyl being illicitly sold as heroin with naloxone nasal spray: A case report.
Topics: Buprenorphine, Naloxone Drug Combination; Drug Overdose; Fentanyl; First Aid; Heroin; Heroin Dependence; Humans; Illicit Drugs; Male; Naloxone; Nasal Sprays; Recurrence; Veterans | 2015 |
Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Drug Contamination; Drug Overdose; Female; Fentanyl; Harm Reduction; Heroin; Heroin Dependence; Humans; Illicit Drugs; Interviews as Topic; Male; Middle Aged; Prevalence; Rhode Island; Risk; Surveys and Questionnaires; Young Adult | 2017 |
Methadone to buprenorphine/naloxone induction without withdrawal utilizing transdermal fentanyl bridge in an inpatient setting-Azar method.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Delayed-Action Preparations; Fentanyl; Humans; Inpatients; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2018 |
What should clinicians do as fentanyl replaces heroin?
Topics: Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Fentanyl; Heroin | 2019 |
High-dose buprenorphine for treatment of high potency opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Dose-Response Relationship, Drug; Female; Fentanyl; Humans; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2020 |
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone.
Topics: Adult; Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; Female; Fentanyl; Humans; Male; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Young Adult | 2021 |
A case of buprenorphine-precipitated withdrawal managed with high-dose buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Fentanyl; Humans; Naloxone; Substance Withdrawal Syndrome | 2022 |
Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Cohort Studies; Fentanyl; Humans; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies | 2021 |
Challenges with buprenorphine inductions in the context of the fentanyl overdose crisis: A case series.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Fentanyl; Humans; Naloxone; Narcotic Antagonists; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Delayed-Action Preparations; Female; Fentanyl; Macaca mulatta; Male; Naloxone; Narcotic Antagonists; Opioid-Related Disorders | 2022 |
Predictors of opioid overdose during the COVID-19 pandemic: The role of relapse, treatment access and nonprescribed buprenorphine/naloxone.
Topics: Analgesics, Opioid; Buprenorphine, Naloxone Drug Combination; COVID-19; Drug Overdose; Fentanyl; Humans; Naloxone; Opiate Overdose; Pandemics; Recurrence | 2023 |